|
|
cas 10417-94-4 |
CLASS CARDIOVASCULAR ADJUNCT TO DIET TO REDUCE TRIGLYCERIDE (TG) LEVELS IN ADULT PATIENTS WITH SEVERE (>= 500 MG/DL) HYPERTRIGLYCERIDEMIA POTENTIAL MECHANISMS OF ACTION INCLUDE INCREASED BETA-OXIDATION INHIBITION OF ACYL-COA:1,2-DIACYLGLYCEROL ACYLTRANSFERASE (DGAT) DECREASED LIPOGENESIS IN THE LIVER AND INCREASED PLASMA LIPOPROTEIN LIPASE ACTIVITY |
|
NATURAL MOLECULE (link) ATC code
|
PK parameters VD 88 LITER Cl 0.68 LITER / HOUR PPB 99 PERCENT t1/2 89 HOUR
|
Target- PDB 1IGX (CRYSTAL STRUCTURE OF EICOSAPENTANOIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.) Ligand code = EPA (link to the list of PDB complexes) Download experimental 3D coordinates of EPA with added hydrogens |
DrugCentral Unknown |
Download SDF file |
5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)- Formula: C20H30O2 Calculated chemical properties: MW 301.43 NB_atoms 22 XLogP 4.66 PSA 35.771 NB_HD 0 NB_HA 2 fsp3 0.45 Lipinski(0=no;1=yes) 1 |
|
Other links: PubChem ChemicalProbes U.S. repository of Clinical Trials VigiAccess SIDER side effects ChemSynthesis Patent@SureChEMBL |